We scan new podcasts and send you the top 5 insights daily.
Contrary to the common view of IBD as an autoimmune disease, it's more accurately described as the immune system mistakenly identifying the gut microbiome as an enemy. It attacks the microbes, and the intestines are damaged as collateral, rather than being the primary target of the immune response.
The trillions of microbes in our gut are not passive residents; they engage in a constant dialogue with immune cells. This "conversation" is critical for calibrating the immune system, teaching it what to attack (pathogens) and what to tolerate (food, benign germs), preventing both infections and autoimmunity.
Humans evolved a robust inflammatory response to fight constant threats like infections. In today's relatively sterile world, this powerful system lacks its historical targets and can overreact to modern triggers, leading to the chronic low-level inflammation that is at the heart of many modern diseases.
The gut barrier is a single cell layer protecting your immune system. When it weakens (leaky gut), food particles and toxins cross over into the bloodstream, triggering a 24/7 immune response. This constant, low-level battle is the primary driver of chronic low-grade inflammation throughout the body.
In the crowded Inflammatory Bowel Disease (IBD) market, most drugs focus on immune suppression. MRM Health’s lead asset differentiates itself with a novel mechanism of action. It aims to restore the microbiome and heal the gut's epithelial lining, addressing the root cause of inflammation rather than just managing symptoms.
Despite many approved drugs for Inflammatory Bowel Disease (IBD), single-mechanism therapies consistently fail to get more than 30% of patients into remission. This recognized "therapeutic ceiling" exists because IBD is a multi-faceted disease. The next breakthrough requires attacking multiple biological pathways simultaneously with combination drugs to achieve significantly higher efficacy.
Our immune systems evolved to mount robust inflammatory responses against acute threats like infections and traumas. In the modern world, which lacks these constant threats, this same sensitivity causes our bodies to overreact to environmental triggers. This evolutionary mismatch creates the chronic, low-level inflammation that drives modern diseases.
The immune system must balance being aggressive against foreign threats while not attacking the body's own cells. T-cells that recognize "self-antigens" sometimes escape the thymus. Autoimmune diseases emerge when these secondary checks fail, causing the immune system to attack healthy tissues like joints or the brain.
The immune system deploys powerful "weapons" to fight invaders. However, an over-activated response, triggered by proteins like C5a, can cause these weapons to harm the body's own organs and tissues, similar to the collateral damage from a dirty bomb.
The gut lining is a major interface with the outside world populated by immune cells. These cells learn to distinguish harmless food from threats. If the gut lining is damaged, immune cells may misinterpret foods as threats, leading to allergies or sensitivities.
The microbes in our gut are essential for training our immune systems. Research on germ-free mice shows they develop major health problems, including deformed organs and immune systems that can't fight germs effectively yet are prone to attacking the body's own tissues. This highlights the danger of overly sterile environments.